This table from Px Wire January-March 2014 Volume 7, No.1 examines why the global systems for tracking voluntary medical male circumcision are lagging behind the actual progress being made.
Voluntary Medical Male Circumcision: What Gets Counted
AIDS Vaccine Science: What’s all the buzz about?
This is training exercise designed to bring HIV vaccine research information to life.
AIDS Vaccine Science for Busy Advocates – Current AIDS Vaccine R&D Pipeline
One-pager reviewing what we’ve learned from previous efficacy trials, the product pipeline and where we are today and future directions toward finding a vaccine that works.
AIDS Vaccine Research: An overview
This series of infographics highlights the current state of the field. Each research area is expanded with key details about the current focus and advancements in the science along with critical issues that advocates should be tracking.
HIV Vaccines by the Numbers: Trials, discoveries, money and more
We know that an AIDS vaccine is possible and that a vaccine will be an important part of a long-term strategy to end the AIDS epidemic. The road ahead is long, but clinical trials—even those with disappointing results—and early-stage research provide critical clues to the way forward. This graphics represents key facts about the AIDS vaccine field.
AIDS Vaccine Science for Busy Advocates – Current AIDS Vaccine R&D Pipeline
One-pager reviewing what we’ve learned from previous efficacy trials, the product pipeline and where we are today and future directions toward finding a vaccine that works.
AIDS Vaccine Science for Busy Advocates – RV144: Building on a breakthrough
A one-page document describing RV144, the first AIDS vaccine trial to show protection against HIV in humans, and plans to further this research.
AIDS Vaccine Science for Busy Advocates – Passive Immunization: An important piece of the puzzle
A one-page document describing passive immunization, the transfer of pre-made antibodies, and its potential for HIV prevention.
HIV Vaccines: Key messages
This is a three-page document providing main points surrounding vaccine research. For a shorter one-page version of this, click here.
2005 AVAC Report: AIDS Vaccines at the Crossroads
This year’s Report offers recommendations for the field in general, the Global HIV Vaccine Enterprise, policy makers, researchers and communities. Some of these recommendations will be familiar because AVAC has made them before, and they are reiterated because it is AVAC’s belief that they are still needed. The Report also provides an update on tenofovir pre-exposure prophylaxis research.